Description
A potent Aurora kinase inhibitor (Kis = 8.0 and 9.2 nM for Aurora A and B kinases, respectively); selective over against a panel of CDKs and other kinases, with the exception of Flt-3 (Ki = 44 nM); exhibits broad-spectrum antiproliferative activity against a panel of human cancer cell lines (mean IC50 = 0.54 µM); orally bioavailable
Formal name: 4-(2-amino-4-methyl-5-thiazolyl)-N-[4-(4-morpholinyl)phenyl]-2-pyrimidinamine
Synonyms:
Molecular weight: 368.5
CAS: 693228-63-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Aurora||Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|Aurora Signaling||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling